Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0BA8M
|
|||
| Former ID |
DIB011313
|
|||
| Drug Name |
LY-295501
|
|||
| Synonyms |
ILX-295501; N1-(3,4-Dichlorophenyl)-N2-(2,3-dihydrobenzofuran-5-ylsulfonyl)urea; 1-(3,4-Dichlorophenyl)-3-(2,3-dihydrobenzofuran-5-ylsulfonyl)urea
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Diabetic complication [ICD-11: 5A2Y; ICD-9: 253.5, 588.1] | Phase 2 | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C15H12Cl2N2O4S
|
|||
| Canonical SMILES |
C1COC2=C1C=C(C=C2)S(=O)(=O)NC(=O)NC3=CC(=C(C=C3)Cl)Cl
|
|||
| InChI |
1S/C15H12Cl2N2O4S/c16-12-3-1-10(8-13(12)17)18-15(20)19-24(21,22)11-2-4-14-9(7-11)5-6-23-14/h1-4,7-8H,5-6H2,(H2,18,19,20)
|
|||
| InChIKey |
VAMFSFIPDOODFH-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 150869-74-2
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00005645) ILX-295501 in Treating Patients With Stage III or Stage IV Ovarian Cancer That Has Not Responded to Previous Treatment. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.